Adopting Digital Promotional Strategies to Support HCP and Patient Engagement in a COVID-19 World

August 25, 2020

Hosted by MATTER. August 26th, 12p – 1:00p CST 

 Digital Health Transformation Forum 

rMark Bio CEO, Jason Smith, will be joining a round-table of industry experts from leading global Pharmaceutical companies to discuss HCP engagement strategics in a COVID-19 world.

Digital technologies and data science tools are playing an increasing role in transitioning traditional asset-focused pharmaceutical and medical device companies into solution companies focused on enhancing patient and provider engagement and experience. In response to a more patient- and value-driven model of care, these life sciences companies are seeking opportunities to strengthen and enhance their offerings by incorporating digital health solutions throughout the value spectrum, from upstream R&D and early development, to downstream clinical trials, market access and commercialization. 

This series convenes pharmaceutical and medical device leaders to problem-solve around key business challenges, with an eye towards uncovering key technological, business process and infrastructure innovations that will accelerate their digital transformation efforts.